Finally, recurrent pyoderma gangrenosum treated with Adalimumab: Case report and review of the literature

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 6, 2015, Pages 1245-1247

  Campanati, A ^a   Brisigotti, V ^a   Ganzetti, G ^a   Molinelli, E ^a   Giuliodori, K ^a   Consales, V ^a   Racchini, S ^a   Bendia, E ^a   Offidani, A ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; BECLOMETASONE DIPROPIONATE; C REACTIVE PROTEIN; CALGRANULIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANTIBIOTIC THERAPY; CASE REPORT; COLONOSCOPY; CORTICOSTEROID THERAPY; CROHN DISEASE; CUSHING SYNDROME; DEBRIDEMENT; DERMATITIS; DIAGNOSTIC ERROR; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOAM DRESSING; HISTOPATHOLOGY; HUMAN; HYDROGEL DRESSING; INTESTINE ULCER; LETTER; MIDDLE AGED; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RECURRENT DISEASE; SECONDARY INFECTION; SKIN ABSCESS; SKIN DEFECT; SKIN ULCER; ULCER; VASCULITIS; COMPLICATION; RETREATMENT;

ADALIMUMAB; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROHN DISEASE; FEMALE; HUMANS; MIDDLE AGED; PYODERMA GANGRENOSUM; RECURRENCE; RETREATMENT;

EID: 84929653655     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12703     Document Type: Letter

References (10)

1. Wollina U,. Pyoderma gangrenosum:a review. Orphanet J Rare Dis 2007; 2: 19.
2. Kontochristopoulos GJ, Stavropoulos PG, Gregoriou S, Zakopoulou N,. Treatment of Pyoderma gangrenosum with low-dose colchicine. Dermatology 2004; 209: 233-236.
3. Campanati A, Ganzetti G, Di Sario A, et al,. The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. J Gastroenterol 2013; 48: 839-846.
4. Campanati A, Giuliodori K, Ganzetti G, Liberati G, Offidani AM,. A patient with psoriasis and vitiligo treated with etanercept. Am J Clin Dermatol 2010; 11 (Suppl 1): 46-48.
5. Agarwal A, Andrews JM,. Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy. Aliment Pharmacol Ther 2013; 38: 563-572.
6. Ganzetti G, Campanati A, Offidani A,. Alopecia Areata: a possible extraintestinal manifestation of Crohn's disease. J Crohns Colitis 2012; 6: 962-963.
7. Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G,. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol 2009; 23: 1008-1017.
8. Wollina U, Tchernev G,. Pyoderma gangrenosum: pathogenetic oriented treatment approaches. Wien Med Wochenschr 2014; 164: 263-273.
9. Hubbard VG, Friedmann AC, Goldsmith P,. Systemic pyoderma gangrenosum responding to infliximab and adalimumab. Br J Dermatol 2005; 152: 1059-1061.
10. Kleinpenning MM, Langewouters AM, Van De Kerkhof PC, Greebe RJ,. Severe pyoderma gangrenosum unresponsive to etanercept and adalimumab. J Dermatolog Treat 2011; 22: 261-265.